Global Plasma-Derived Therapies Market Report

1. Global Plasma-Derived Therapies Market Research Report
1. 1.1 Study Objectives
2. 1.2 Global Plasma-Derived Therapies Market - Overview
3. 1.3 Reason to Read This Report
4. 1.4 Methodology and Forecast Analysis
2. Global Plasma-Derived Therapies Market Research Report - Preface
1. 2.1 Global Plasma-Derived Therapies Market Research Report – Detailed Scope and Definitions
1. 2.1.1 By Product
2. 2.1.2 By Indication
3. 2.1.3 By End-user
4. 2.1.4 By Distribution Channel
5. 2.1.5 By Region
3. Global Plasma-Derived Therapies Market Dynamics
1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
2. 3.2. Restraints – By Product, By Indication, By End-user, By Distribution Channel, By Country
3. 3.3. Opportunities – By Product, By Indication, By End-user, By Distribution Channel, By Country
4. 3.4. Trends – By Product, By Indication, By End-user, By Distribution Channel, By Country
5. 3.5. PEST Analysis
6. 3.6. Porters Five Rule Analysis
7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
8. 3.8. Global Plasma-Derived Therapies Market Research Report – DROTs Impact Analysis
4. Global Plasma-Derived Therapies Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
1. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
3. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
4. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5. Global Plasma-Derived Therapies Market, By Product, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 5.1 Immunoglobulins
1. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
2. 5.2 Coagulation Factors
1. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
3. 5.3 Albumin
1. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
4. 5.4 Others
1. 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6. Global Plasma-Derived Therapies Market, By Indication, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 6.1 Hemophilia
1. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
2. 6.2 Immunodeficiency Disorders
1. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
3. 6.3 Neurological Disorders
1. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
4. 6.4 Others
1. 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
7. Global Plasma-Derived Therapies Market, By End-user, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 7.1 Hospitals
1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
2. 7.2 Specialty Clinics
1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
3. 7.3 Homecare
1. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
8. Global Plasma-Derived Therapies Market, By Distribution Channel, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 8.1 Direct Sales
1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
2. 8.2 Distributors.
1. 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
9. Global Plasma-Derived Therapies Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
1. 9.1 North America
   1. 9.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
   2. 9.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
   3. 9.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
   4. 9.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
2. 9.2 Europe
   1. 9.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
   2. 9.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
   3. 9.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
   4. 9.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
3. 9.3 Asia-Pacific
   1. 9.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
   2. 9.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
   3. 9.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
   4. 9.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
4. 9.4 Latin America
   1. 9.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
   2. 9.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
   3. 9.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
   4. 9.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5. 9.5 Middle East & Africa
   1. 9.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
   2. 9.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
   3. 9.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
   4. 9.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
9.6 Global Plasma-Derived Therapies Market - Opportunity Analysis Index, By Product, By Indication, By End-user, By Distribution Channel, and Region, 2024 - 2031
10. North America Global Plasma-Derived Therapies Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
10.1 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 10.1.1 Immunoglobulins
2. 10.1.2 Coagulation Factors
3. 10.1.3 Albumin
4. 10.1.4 Others
10.2 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 10.2.1 Hemophilia
2. 10.2.2 Immunodeficiency Disorders
3. 10.2.3 Neurological Disorders
4. 10.2.4 Others
10.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 10.3.1 Hospitals
2. 10.3.2 Specialty Clinics
3. 10.3.3 Homecare
10.4 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 10.4.1 Direct Sales
2. 10.4.2 Distributors.
10.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 10.5.1 United States
2. 10.5.2 Canada
10.6 North America Global Plasma-Derived Therapies Market – Opportunity Analysis Index, By Product, By Indication, By End-user, By Distribution Channel, and Country, 2024 - 2031
10.7 Regional Trends Analysis
10.8 North America Global Plasma-Derived Therapies Market Research Report - Company Profiles
1. 10.8.1 Company 1 (United States)
2. 10.8.2 Company 2 (Canada)
3. 10.8.3 Company 3 (Canada)
11. Europe Global Plasma-Derived Therapies Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
11.1 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 11.1.1 Immunoglobulins
2. 11.1.2 Coagulation Factors
3. 11.1.3 Albumin
4. 11.1.4 Others
11.2 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 11.2.1 Hemophilia
2. 11.2.2 Immunodeficiency Disorders
3. 11.2.3 Neurological Disorders
4. 11.2.4 Others
11.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 11.3.1 Hospitals
2. 11.3.2 Specialty Clinics
3. 11.3.3 Homecare
11.4 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 11.4.1 Direct Sales
2. 11.4.2 Distributors.
11.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 11.5.1 Germany
2. 11.5.2 United Kingdom
3. 11.5.3 France
4. 11.5.4 Spain
5. 11.5.5 Italy
6. 11.5.6 Russia
7. 11.5.7 Netherlands
8. 11.5.8 Poland
9. 11.5.9 Rest of Europe
11.6 Europe Global Plasma-Derived Therapies Market – Opportunity Analysis Index, By Product, By Indication, By End-user, By Distribution Channel, and Country, 2024 - 2031
11.7 Regional Trends Analysis
11.8 Europe Global Plasma-Derived Therapies Market Research Report - Company Profiles
1. 11.8.1 Company 1 (Germany)
2. 11.8.2 Company 2 (United Kingdom)
3. 11.8.3 Company 3 (United Kingdom)
12. Asia-Pacific Global Plasma-Derived Therapies Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
12.1 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 12.1.1 Immunoglobulins
2. 12.1.2 Coagulation Factors
3. 12.1.3 Albumin
4. 12.1.4 Others
12.2 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 12.2.1 Hemophilia
2. 12.2.2 Immunodeficiency Disorders
3. 12.2.3 Neurological Disorders
4. 12.2.4 Others
12.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 12.3.1 Hospitals
2. 12.3.2 Specialty Clinics
3. 12.3.3 Homecare
12.4 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 12.4.1 Direct Sales
2. 12.4.2 Distributors.
12.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 12.5.1 China
2. 12.5.2 Japan
3. 12.5.3 India
4. 12.5.4 South Korea
5. 12.5.5 Australia & NZ
6. 12.5.6 ASEAN
7. 12.5.7 Rest of Asia-Pacific
12.6 Asia-Pacific Global Plasma-Derived Therapies Market – Opportunity Analysis Index, By Product, By Indication, By End-user, By Distribution Channel, and Country, 2024 - 2031
12.7 Regional Trends Analysis
12.8 Asia-Pacific Global Plasma-Derived Therapies Market Research Report - Company Profiles
1. 12.8.1 Company 1 (China)
2. 12.8.2 Company 2 (Japan)
3. 12.8.3 Company 3 (Japan)
13. Latin America Global Plasma-Derived Therapies Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
13.1 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 13.1.1 Immunoglobulins
2. 13.1.2 Coagulation Factors
3. 13.1.3 Albumin
4. 13.1.4 Others
13.2 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 13.2.1 Hemophilia
2. 13.2.2 Immunodeficiency Disorders
3. 13.2.3 Neurological Disorders
4. 13.2.4 Others
13.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 13.3.1 Hospitals
2. 13.3.2 Specialty Clinics
3. 13.3.3 Homecare
13.4 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 13.4.1 Direct Sales
2. 13.4.2 Distributors.
13.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 13.5.1 Brazil
2. 13.5.2 Mexico
3. 13.5.3 Argentina
4. 13.5.4 Peru
5. 13.5.5 Colombia
6. 13.5.6 Rest of Latin America
13.6 Latin America Global Plasma-Derived Therapies Market – Opportunity Analysis Index, By Product, By Indication, By End-user, By Distribution Channel, and Country, 2024 - 2031
13.7 Regional Trends Analysis
13.8 Latin America Global Plasma-Derived Therapies Market Research Report - Company Profiles
1. 13.8.1 Company 1 (Brazil)
2. 13.8.2 Company 2 (Mexico)
3. 13.8.3 Company 3 (Mexico)
14. Middle East & Africa Global Plasma-Derived Therapies Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
14.1 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 14.1.1 Immunoglobulins
2. 14.1.2 Coagulation Factors
3. 14.1.3 Albumin
4. 14.1.4 Others
14.2 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 14.2.1 Hemophilia
2. 14.2.2 Immunodeficiency Disorders
3. 14.2.3 Neurological Disorders
4. 14.2.4 Others
14.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 14.3.1 Hospitals
2. 14.3.2 Specialty Clinics
3. 14.3.3 Homecare
14.4 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 14.4.1 Direct Sales
2. 14.4.2 Distributors.
14.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 14.5.1 Saudi Arabia
2. 14.5.2 UAE
3. 14.5.3 South Africa
4. 14.5.4 Egypt
5. 14.5.5 Israel
6. 14.5.6 Rest of Middle East and Africa
14.6 Middle East & Africa Global Plasma-Derived Therapies Market – Opportunity Analysis Index, By Product, By Indication, By End-user, By Distribution Channel, and Country, 2024 - 2031
14.7 Regional Trends Analysis
14.8 Middle East & Africa Global Plasma-Derived Therapies Market Research Report - Company Profiles
1. 14.8.1 Company 1 (Saudi Arabia)
2. 14.8.2 Company 2 (UAE)
3. 14.8.3 Company 3 (UAE)
15. Competition Landscape
15.1 Strategic Dashboard of Top Market Players
15.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)

1. 15.2.1 CSL Behring
2. 15.2.2 Grifols S.A.
3. 15.2.3 Takeda Pharmaceutical Company
4. 15.2.4 Octapharma AG
5. 15.2.5 Kedrion Biopharma
6. 15.2.6 LFB Group
7. 15.2.7 Biotest AG
8. 15.2.8 Sanquin
9. 15.2.9 China Biologic Products Holdings
10. 15.2.10 BPL (Bio Products Laboratory).
16. Data Collection Method and Research Approach
17. Principal Presumptions and Acronyms